The going has been good for the German pharmaceutical giant Bayer BAYRY this year. Shares have surged 62.9% year to date ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

AbbVie has acquired global rights to the lead pipeline asset of Ichnos Glenmark Innovation (IGI), the cancer and autoimmune disease candidate ISB 2001, through an exclusive licensing agreement that ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

The chronic urticaria epidemiology report provides a detailed analysis of the current marketed drugs and late-stage pipeline ...

New York State Common Retirement Fund trimmed its Regeneron stake by 5% in Q1, selling over 6,800 shares worth millions.

New York State Common Retirement Fund trimmed its Lockheed Martin holdings by 12% in Q1, shedding over 33,000 shares. The ...